Insider Trends: Amphastar Pharmaceuticals Insider Continues 90-Day Selling Trend
10:52 PM EST, 02/05/2021 (MT Newswires) -- On Feb 03, 2021, Dr Jack Y Zhang, 10% Owner, Director and CEO & Chief Scientific Officer, reported a sale of 41,869 shares in Amphastar Pharmaceuticals (AMPH) for $782,343. Subsequent to the Form 4 filing with the SEC, Dr Zhang has control over a total of 10,649,828 shares of company stock, with 2,246,988 shares held directly and 8,402,840 controlled indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $202 million.
During the most recent 90-day period, prior to the date of this filing, there have been 4 transactions reported to the SEC, all of which have been sales and have resulted in the disposition of 45,565 company shares by insiders. Relative to the preceding 90-day window of time, there were 6 transactions from 4 insiders that resulted in the net disposition of 12,012 shares.
This level of insider transactions is below that of the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 59.1 transactions per company, and disposition of 8,109 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1297184/000110465921013185/xslF345X03/a4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.